Syndax Pharmaceuticals
-
2005
Company Description
Syndax Pharmaceuticals is focused on developing an HDAC inhibitor for solid tumors and hematological tumors.
Syndax Pharmaceuticals specializes is a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumors
-
Manufacturer:
Science and Engineering -
Formed:
2005 -
Company Website:
-
Company E-mail:
-
Company Address:
460 Totten Pond Road, Suite 650Waltham, MAUnited States -
CEO:
- Joanna C. Horobin
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits